DUTCH BROS INC-CLASS A (BROS)

US26701L1008 - Common Stock

52.07  -0.55 (-1.05%)

After market: 52.24 +0.17 (+0.33%)

Fundamental Rating

4

BROS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of BROS is average, but there are quite some concerns on its profitability. BROS is valued quite expensively, but it does show have an excellent growth rating.



3

1. Profitability

1.1 Basic Checks

BROS had positive earnings in the past year.
In the past year BROS had a positive cash flow from operations.
In multiple years BROS reported negative net income over the last 5 years.
Each year in the past 5 years BROS had a positive operating cash flow.

1.2 Ratios

BROS has a Return On Assets (1.24%) which is in line with its industry peers.
BROS has a better Return On Equity (5.78%) than 62.69% of its industry peers.
BROS has a Return On Invested Capital of 2.67%. This is in the lower half of the industry: BROS underperforms 66.42% of its industry peers.
Industry RankSector Rank
ROA 1.24%
ROE 5.78%
ROIC 2.67%
ROA(3y)-0.87%
ROA(5y)2.85%
ROE(3y)-5.56%
ROE(5y)3.94%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BROS's Profit Margin of 2.54% is in line compared to the rest of the industry. BROS outperforms 49.25% of its industry peers.
BROS has a Operating Margin (8.58%) which is in line with its industry peers.
BROS's Operating Margin has improved in the last couple of years.
BROS has a worse Gross Margin (28.65%) than 78.36% of its industry peers.
In the last couple of years the Gross Margin of BROS has declined.
Industry RankSector Rank
OM 8.58%
PM (TTM) 2.54%
GM 28.65%
OM growth 3Y16.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BROS is destroying value.
BROS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BROS has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.24 indicates that BROS is not in any danger for bankruptcy at the moment.
BROS has a better Altman-Z score (3.24) than 80.60% of its industry peers.
BROS has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.13, BROS is in the better half of the industry, outperforming 60.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Altman-Z 3.24
ROIC/WACC0.3
WACC8.8%

2.3 Liquidity

A Current Ratio of 1.90 indicates that BROS should not have too much problems paying its short term obligations.
The Current ratio of BROS (1.90) is better than 82.84% of its industry peers.
BROS has a Quick Ratio of 1.68. This is a normal value and indicates that BROS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BROS (1.68) is better than 82.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.68

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.00% over the past year.
Looking at the last year, BROS shows a very strong growth in Revenue. The Revenue has grown by 30.53%.
Measured over the past years, BROS shows a very strong growth in Revenue. The Revenue has been growing by 43.42% on average per year.
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y43.42%
Revenue growth 5YN/A
Sales Q2Q%27.87%

3.2 Future

Based on estimates for the next years, BROS will show a very strong growth in Earnings Per Share. The EPS will grow by 32.69% on average per year.
The Revenue is expected to grow by 22.02% on average over the next years. This is a very strong growth
EPS Next Y42.68%
EPS Next 2Y29.39%
EPS Next 3Y27.79%
EPS Next 5Y32.69%
Revenue Next Year30.23%
Revenue Next 2Y25.37%
Revenue Next 3Y23.77%
Revenue Next 5Y22.02%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

BROS is valuated quite expensively with a Price/Earnings ratio of 108.48.
62.69% of the companies in the same industry are cheaper than BROS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BROS to the average of the S&P500 Index (28.96), we can say BROS is valued expensively.
Based on the Price/Forward Earnings ratio of 100.33, the valuation of BROS can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BROS indicates a slightly more expensive valuation: BROS is more expensive than 66.42% of the companies listed in the same industry.
BROS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 108.48
Fwd PE 100.33

4.2 Price Multiples

80.60% of the companies in the same industry are cheaper than BROS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 44.18

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BROS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BROS's earnings are expected to grow with 27.79% in the coming years.
PEG (NY)2.54
PEG (5Y)N/A
EPS Next 2Y29.39%
EPS Next 3Y27.79%

0

5. Dividend

5.1 Amount

No dividends for BROS!.
Industry RankSector Rank
Dividend Yield N/A

DUTCH BROS INC-CLASS A

NYSE:BROS (11/21/2024, 8:16:02 PM)

After market: 52.24 +0.17 (+0.33%)

52.07

-0.55 (-1.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.03B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 108.48
Fwd PE 100.33
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 5.78%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.58%
PM (TTM) 2.54%
GM 28.65%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.9
Quick Ratio 1.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y42.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.53%
Revenue growth 3Y43.42%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y